Inventor · disambiguated record
Weimin Wang
Also filed as: WANG WEIMIN · WANG WEIMIN MARK
54 granted patents·57 pending applications·1,440 citations·filing 2001–2025
98Inventor score
Files withSIRNA THERAPEUTICS INC31SANEGENE BIO USA INC17DICERNA PHARMACEUTICALS INC15SILA NANOTECHNOLOGIES INC6MERCK SHARP & DOHME4
Top patents by PatentIndex Score
111 records- 0198US7893302B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2009·Granted Feb 22, 2011·152 cites·1 claims
- 0298US7491805B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2004·Granted Feb 17, 2009·273 cites·4 claims
- 0398US7404969B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Jul 29, 2008·363 cites·10 claims
- 0497US7964578B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2008·Granted Jun 21, 2011·66 cites·9 claims
- 0597US7833992B2Conjugates and compositions for cellular deliveryMERCK SHARPE & DOHME·Filed 2003·Granted Nov 16, 2010·149 cites·3 claims
- 0697US7691405B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Apr 6, 2010·51 cites·10 claims
- 0797US7514099B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 7, 2009·67 cites·1 claims
- 0897US6995259B1Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2001·Granted Feb 7, 2006·103 cites·16 claims
- 0994US7777023B2Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·23 cites·20 claims
- 1093US11661604B2Methods and compositions for inhibiting expression of LDHADICERNA PHARMACEUTICALS INC·Filed 2020·Granted May 30, 2023·3 cites·20 claims
- 1193US9299251B2Learning road navigation paths based on aggregate driver behaviorINRIX INC·Filed 2014·Granted Mar 29, 2016·27 cites·25 claims
- 1293US7641915B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Jan 5, 2010·19 cites·1 claims
- 1392US10633375B2Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 28, 2020·6 cites·21 claims
- 1492US7205399B1Methods and reagents for oligonucleotide synthesisSIRNA THERAPEUTICS INC·Filed 2002·Granted Apr 17, 2007·67 cites·20 claims
- 1590US8738285B2Learning road navigation paths based on aggregate driver behaviorSCOFIELD CHRISTOPHER L·Filed 2011·Granted May 27, 2014·20 cites·42 claims
- 1689US9642804B2Cationic lipids with various head groups for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted May 9, 2017·4 cites·17 claims
- 1788US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 1888US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 1988US2025372612A1Electrode with conductive interlayer and method thereofSILA NANOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 2087US2024332552A1Electrode with conductive interlayer and method thereofSILA NANOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 2186US11414659B24'-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2017·Granted Aug 16, 2022·3 cites·44 claims
- 2284US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 2384US9670487B2Cationic lipids for oligonucleotide deliveryCOLLETTI STEVEN L·Filed 2011·Granted Jun 6, 2017·4 cites·7 claims
- 2484US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 2583US8987377B2Poly(amide) polymers for the delivery of oligonucleotidesBARRETT STEPHANIE E·Filed 2011·Granted Mar 24, 2015·7 cites·18 claims
- 2682US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 2782US9931712B2Laser drilling and trepanning deviceWANG WEIMIN·Filed 2012·Granted Apr 3, 2018·7 cites·20 claims
- 2880US11286488B2Methods and compositions for inhibiting expression of LDHADICERNA PHARMACEUTICALS INC·Filed 2018·Granted Mar 29, 2022·1 cites·25 claims
- 2979US12046759B2Electrode with conductive interlayer and method thereofSILA NANOTECHNOLOGIES INC·Filed 2022·Granted Jul 23, 2024·0 cites·24 claims
- 3079US2025283091A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2025·Application pending·0 cites
- 3178US2025353872A1Ligand-Modified OligonucleotidesDICERNA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3277US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 3377US2024182901A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2022·Application pending·0 cites
- 3473US8901101B2Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotidesBUSUEK MARINA·Filed 2011·Granted Dec 2, 2014·2 cites·9 claims
- 3572US8691580B2Single chemical entities and methods for delivery of oligonucleotidesAARONSON JEFFREY G·Filed 2011·Granted Apr 8, 2014·2 cites·6 claims
- 3671US9257042B2Learning road feature delay times based on aggregate driver behaviorSCOFIELD CHRISTOPHER L·Filed 2011·Granted Feb 9, 2016·3 cites·38 claims
- 3771US2020083542A1Electrode with conductive interlayer and method thereofSILA NANOTECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 3870US12037586B24′-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2022·Granted Jul 16, 2024·0 cites·26 claims
- 3970US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4070US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4169US2024301421A1Small interfering rna targeting c3 and uses thereofSANEGENE BIO USA INC·Filed 2024·Application pending·0 cites
- 4269US2025059540A1Double stranded rna targeting angiopoietin-like 3 (angptl-3) and methods of use thereofSANEGENE BIO USA INC·Filed 2024·Application pending·0 cites
- 4368US12037358B2Compositions comprising reversibly modified oligonucleotides and uses thereofDICERNA PHARMACEUTICALS INC·Filed 2022·Granted Jul 16, 2024·0 cites·18 claims
- 4468US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4568US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4668US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4767US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 4867US2024309383A1Small interfering rna targeting hbv and uses thereofSUZHOU SANEGENE BIO INC·Filed 2024·Application pending·0 cites
- 4967US2010105933A1Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesCHEN TONGQIAN·Filed 2009·Application pending·0 cites
- 5067US2024175026A1Small interfering rna targeting c3 and uses thereofSANEGENE BIO USA INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 111 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Weimin Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →